Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66,413,214
-
Total 13F shares
-
17,241,887
-
Share change
-
+306,077
-
Total reported value
-
$81,212,708
-
Put/Call ratio
-
0%
-
Price per share
-
$4.71
-
Number of holders
-
35
-
Value change
-
+$1,546,036
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q4 2023
As of 31 Dec 2023,
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,241,887 shares.
The largest 10 holders included
GENERATION INVESTMENT MANAGEMENT LLP, BANQUE PICTET & CIE SA, CREDIT SUISSE AG/, MILLENNIUM MANAGEMENT LLC, Alta Wealth Advisors LLC, PRINCIPAL FINANCIAL GROUP INC, BlackRock Inc., PURA VIDA INVESTMENTS, LLC, Bank Pictet & Cie (Europe) AG, and Parkman Healthcare Partners LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.